Related Experiment Videos
Serotonergic involvement in haloperidol-induced catalepsy
B S Neal-Beliveau1, J N Joyce, I Lucki
1Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia.
Summary
Serotonin (5-HT) agonists effectively reversed haloperidol-induced catalepsy in rats by acting on specific 5-HT receptor subtypes, not by increasing dopamine release. These findings suggest novel therapeutic strategies for antipsychotic side effects.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Antipsychotic medications like haloperidol (HAL) block dopamine (DA) receptors, leading to catalepsy, a motor side effect.
- Serotonin (5-HT) pathways are implicated in motor control and may influence dopamine receptor blockade.
- Understanding the interaction between serotonin and dopamine systems is crucial for managing antipsychotic-induced side effects.
Purpose of the Study:
- To investigate the ability of selective serotonin (5-HT) compounds to reverse haloperidol (HAL)-induced catalepsy in rats.
- To elucidate the specific serotonin receptor subtypes involved in reversing catalepsy.
- To determine the mechanism by which serotonin agonists counteract dopamine receptor blockade.
Main Methods:
- Rats were treated with haloperidol (HAL) to induce catalepsy.
- Various serotonin receptor agonists (fenfluramine, 8-hydroxy-2-(di-n-propylamino)tetralin, buspirone, 2,5-dimethoxy-4-bromoamphetamine, trifluoromethylphenylpiperazine) and antagonists (pindolol, ketanserin, mianserin) were administered.
- Dose-response curves were analyzed to determine competitive or noncompetitive interactions between HAL and serotonin agonists.
Main Results:
- Fenfluramine, 8-hydroxy-2-(di-n-propylamino)tetralin, and buspirone significantly reversed HAL-induced catalepsy.
- Specific 5-HT receptor subtypes (5-HT1A, 5-HT1C/2) were identified as mediating these effects, confirmed by antagonist studies.
- Serotonin agonists exhibited noncompetitive interactions with haloperidol, unlike the competitive interaction seen with the dopamine agonist apomorphine.
Conclusions:
- Serotonin (5-HT) receptor agonists reverse haloperidol (HAL)-induced catalepsy through direct interactions with specific 5-HT receptor subtypes.
- The mechanism of reversal is not mediated by an indirect increase in dopamine (DA) release.
- Targeting specific 5-HT receptor subtypes offers a promising avenue for developing novel therapeutics to mitigate extrapyramidal side effects of antipsychotics.